Figure 1
Graphic representation of the estimated outcome with 2 different strategies for frontline CML therapy. (A) Standard-dose imatinib first, followed by salvage therapy with second-generation TKI on failure. (B) Second-generation TKI first.
Graphic representation of the estimated outcome with 2 different strategies for frontline CML therapy. (A) Standard-dose imatinib first, followed by salvage therapy with second-generation TKI on failure. (B) Second-generation TKI first.
